Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma (vol 373, pg 23, 2015)

被引:0
|
作者
Chapman, Paul B.
D'Angelo, Sandra P.
Wolchok, Jedd D.
机构
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 22期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2185 / 2185
页数:1
相关论文
共 50 条
  • [1] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma (vol 373, pg 2006, 2015)
    Melero, Ignacio
    Lasarte, Juan J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
  • [2] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    Larkin, J.
    Chiarion-Sileni, V.
    Gonzalez, R.
    Grob, J. J.
    Cowey, C. L.
    Lao, C. D.
    Schadendorf, D.
    Dummer, R.
    Smylie, M.
    Rutkowski, P.
    Ferrucci, P. F.
    Hill, A.
    Wagstaff, J.
    Carlino, M. S.
    Haanen, J. B.
    Maio, M.
    Marquez-Rodas, I.
    McArthur, G. A.
    Ascierto, P. A.
    Long, G. V.
    Callahan, M. K.
    Postow, M. A.
    Grossmann, K.
    Sznol, M.
    Dreno, B.
    Bastholt, L.
    Yang, A.
    Rollin, L. M.
    Horak, C.
    Hodi, F. S.
    Wolchok, J. D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (01): : 23 - 34
  • [3] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
    Valsecchi, Matias E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1270 - 1270
  • [4] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
    Postow, Michael A.
    Chesney, Jason
    Pavlick, Anna C.
    Robert, Caroline
    Grossmann, Kenneth
    McDermott, David
    Linette, Gerald P.
    Meyer, Nicolas
    Giguere, Jeffrey K.
    Agarwala, Sanjiv S.
    Shaheen, Montaser
    Ernstoff, Marc S.
    Minor, David
    Salama, April K.
    Taylor, Matthew
    Ott, Patrick A.
    Rollin, Linda M.
    Horak, Christine
    Gagnier, Paul
    Wolchok, Jedd D.
    Hodi, F. Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21): : 2006 - 2017
  • [5] HEALTHCARE COST COMPARISON ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA
    Potluri, R.
    Bhandari, H.
    Ranjan, S.
    Moshyk, A.
    Kotapati, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S72 - S73
  • [6] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Ravi Potluri
    Sandip Ranjan
    Hitesh Bhandari
    Helen Johnson
    Andriy Moshyk
    Srividya Kotapati
    [J]. Experimental Hematology & Oncology, 8
  • [7] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma (vol 377, pg 1345, 2017)
    Larkin, J.
    Chiarion-Sileni, V.
    Gonzalez, R.
    Grob, J. J.
    Cowey, C. L.
    Lao, C. D.
    Schadendorf, D.
    Dummer, R.
    Smylie, M.
    Rutkowski, P.
    Ferrucci, P. F.
    Hill, A.
    Wagstaff, J.
    Carlino, M. S.
    Haanen, J. B.
    Maio, M.
    Marquez-Rodas, I.
    McArthur, G. A.
    Ascierto, P. A.
    Long, G. V.
    Callahan, M. K.
    Postow, M. A.
    Grossmann, K.
    Sznol, M.
    Dreno, B.
    Bastholt, L.
    Yang, A.
    Rollin, L. M.
    Horak, C.
    Hodi, F. S.
    Wolchok, J. D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
  • [8] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Potluri, Ravi
    Ranjan, Sandip
    Bhandari, Hitesh
    Johnson, Helen
    Moshyk, Andriy
    Kotapati, Srividya
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (1)
  • [9] COMPARISON OF HEALTHCARE COSTS IN FRANCE OF COMBINATION NIVOLUMAB AND IPILIMUMAB TREATMENT VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA
    Bregman, B.
    Moshyk, A.
    Johnson, H. M.
    Potluri, R.
    Bhandari, H.
    Ranjan, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S441 - S441
  • [10] Nivolumab and Ipilimumab in Advanced Melanoma (vol 377, pg 2503, 2017)
    Eggermont, A. M. M.
    Chiarion-Sileni, V.
    Grob, J. -J.
    Dummer, R.
    Wolchok, J. D.
    Schmidt, H.
    Hamid, O.
    Robert, C.
    Ascierto, P. A.
    Richards, J. M.
    Lebbe, C.
    Ferraresi, V.
    Smylie, M.
    Weber, J. S.
    Maio, M.
    Bastholt, L.
    Mortier, L.
    Thomas, L.
    Tahir, S.
    Hauschild, A.
    Hassel, J. C.
    Hodi, F. S.
    Taitt, C.
    de Pril, V.
    de Schaetzen, G.
    Suciu, S.
    Testori, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185